DIABETIC RETINOPATHY (DR)
Clinical trials for DIABETIC RETINOPATHY (DR) explained in plain language.
Never miss a new study
Get alerted when new DIABETIC RETINOPATHY (DR) trials appear
Sign up with your email to follow new studies for DIABETIC RETINOPATHY (DR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drug shows promise for diabetes-related vision loss
Disease control CompletedThis study tested the drug faricimab in 60 people with diabetic retinopathy, a diabetes complication that can damage eyesight. Researchers used special eye scans to see if the drug could reduce abnormal cells on blood vessels and restore protective yellow pigment in the macula. T…
Matched conditions: DIABETIC RETINOPATHY (DR)
Sponsor: Federico II University • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Hidden eye damage: diabetes changes retinal vessels even without visible disease
Knowledge-focused CompletedThis study looked at 200 people with type 2 diabetes who had no signs of diabetic eye disease during a regular eye exam. Researchers used a special imaging technique called OCTA to measure tiny blood vessels in the back of the eye. The goal was to see if the length of time someon…
Matched conditions: DIABETIC RETINOPATHY (DR)
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated May 17, 2026 13:08 UTC
-
Phone game could replace eye clinic visits for diabetics
Knowledge-focused CompletedThis study tested whether people with diabetes can use a smartphone game app to monitor their vision at home. 55 participants at high risk for diabetic retinopathy played vision games on their phones for 6 months. The goal was to see if this approach is practical and acceptable, …
Matched conditions: DIABETIC RETINOPATHY (DR)
Sponsor: Queen's University, Belfast • Aim: Knowledge-focused
Last updated May 11, 2026 20:53 UTC